HOME > COLUMN
COLUMN
-
Reputable Combination
July 11, 2017
-
What Is the Best Path to Customers’ Hearts and Minds?
June 19, 2017
-
Doubling Down on Digital
May 26, 2017
-
Global Opportunities for Global Minds
April 21, 2017
-
Will Tepid Pricing Debate Only Go Full-Throttle after Golden Week Holidays?
March 30, 2017
-
Some Japanese Pharmaceutical Workers May Slowly Be Working Themselves to Death
March 17, 2017
-
The Best Recruiters Are Just a Little Paranoid
February 17, 2017
-
5 Killer Questions for HR to Ask Recruiters
January 20, 2017
-
What Pharma Can Learn from the Airline Industry
December 16, 2016
-
Near Death at Singapore General Hospital and 5 Lessons I Learnt
October 20, 2016
-
Reasons for a “Hold”
August 9, 2016
-
It’s Time for Market Access to Play a Leading Role
April 22, 2016
-
Biosimilars Are the New Black
March 25, 2016
-
Technology Provides Opportunities for Medical Device Companies
February 18, 2016
-
Don’t Accept the Offer
January 22, 2016
-
It’s Your Choice
December 18, 2015
-
Ask a Question and Shut Up
November 27, 2015
-
Recruiternomics
October 30, 2015
-
Pharma Companies in JPAC Are Searching for the Goldilocks Candidate
September 25, 2015
-
No… Your Company Is Not like a Family!
August 28, 2015
ページ
I recently attended a fantastic conference hosted by Prospection Japan, and one speaker, Dr. Joe Ledsam, really blew me away with his insights. He shared some truly fascinating developments about how AI is set to revolutionize healthcare, from how doctors…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…